NCT00853840View on ClinicalTrials.gov

Study To Investigate The Hemodynamic Effects Of Single Dose Vardenafil In Subjects Receiving Maraviroc

PHASE4CompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

April 30, 2008

Primary Completion Date

May 31, 2008

Study Completion Date

May 31, 2008

Conditions
AIDS
Interventions
DRUG

Maraviroc

Maraviroc 300 mg twice daily for 3 - 4 days plus a single oral dose of Vardenafil 20 mg.

DRUG

Vardenafil

Maraviroc 300 mg twice daily for 3 - 4 days plus a single oral dose of Vardenafil 20 mg.

DRUG

Maraviroc

Maraviroc 300 mg twice daily for 3 - 4 days plus a single oral dose of Placebo.

DRUG

Placebo

Maraviroc 300 mg twice daily for 3 - 4 days plus a single oral dose of Placebo.

Trial Locations (1)

1070

Pfizer Investigational Site, Brussels

Sponsors

Lead Sponsor

ViiV Healthcare

Collaborators (1)

Pfizer
All Listed Sponsors
collaborator

Pfizer

INDUSTRY

lead

ViiV Healthcare

INDUSTRY